SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer

by Johnson R, Sabnis N, Sun X, Ahluwalia R, Lacko AG
Published 2017-06-01

Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles

by Sabnis N, Nair M, Israel M, McConathy WJ, Lacko AG
Published 2012-02-01